Net profit of Senores Pharmaceuticals rose 152.18% to Rs 32.38 crore in the quarter ended September 2025 as against Rs 12.84 crore during the previous quarter ended September 2024. Sales rose 56.08% to Rs 153.36 crore in the quarter ended September 2025 as against Rs 98.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales153.3698.26 56 OPM %32.2823.68 - PBDT48.7319.86 145 PBT40.6415.97 154 NP32.3812.84 152 Powered by Capital Market - Live News

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 6 November 2025.Powered by Capital Market - Live News

Senores Pharmaceuticals announced that the 8th Annual General Meeting(AGM) of the company will be held on 18 September 2025.Powered by Capital Market - Live News

Net profit of Senores Pharmaceuticals rose 83.88% to Rs 19.73 crore in the quarter ended June 2025 as against Rs 10.73 crore during the previous quarter ended June 2024. Sales rose 63.90% to Rs 130.30 crore in the quarter ended June 2025 as against Rs 79.50 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales130.3079.50 64 OPM %26.2226.82 - PBDT32.4816.98 91 PBT26.4913.46 97 NP19.7310.73 84 Powered by Capital Market - Live News

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 July 2025.Powered by Capital Market - Live News